intelligence360
  • About us
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Route 92 Medical plans new construction project in West Jordan, Utah

Route 92 Medical plans new construction project in West Jordan, Utah

April 28, 2026 Craig Etkin

West Jordan, Utah — According to state and local development sources, Route 92 Medical plans to invest $5 Million to build out new space in West Jordan. The company is creating 116 new jobs at this facility. The company plans to occupy the new space in West Jordan, on or about December 1, 2026. According to the company website Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the worlds leading clinicians with the goal of improving procedural and patient outcomes. The Monopoint operating platform received U.S. FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.

To learn more about Route 92 Medical, visit https://www.route92medical.com/

Company Contact:
Route 92 Medical
1375 West 8040 South
West Jordan, UT84088
Phone: 650-581-1179
LinkedIn Link: https://www.linkedin.com/company/route-92-medical/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.


Uncategorized
7160, Commercial Relocation, intelligence360, Route 92 Medical, Salt Lake City-Ogden, Utah, West Jordan

Post navigation

NEXT
FANUC America plans new construction project in Auburn Hills, Michigan
PREVIOUS
Pulmuone Foods USA plans new construction project in Ayer, Massachusetts
Comments are closed.

Categories

Recent Posts

  • Epicrispr Biotechnologies has raised $90 Million in new Series C funding August 19, 2026
  • Executive Change: GATX Corporation (NYSE: GATX) Appoints Eren Doygun as Senior Vice President, Chief Planning and Investment Officer August 19, 2026
  • Executive Change: FinQuery Appoints Ryan Grace as Chief Revenue Officer August 19, 2026
  • Executive Change: Fiduciary Trust Company Appoints Eric Cunnane as Chief Fiduciary Officer August 19, 2026

Archives

© 2026   Copyright SI360 Inc. All Rights Reserved.